Cardiotrophin-1 attenuates experimental colitis in mice.

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Cardiotrophin-1 (CT-1) exhibits protective effects in various organs.
• The role of CT-1 in ulcerative colitis (UC) pathogenesis and treatment remains to be fully elucidated.

Purpose of the Study:

• To investigate the role of endogenous CT-1 in experimental UC.
• To evaluate the therapeutic potential of exogenous CT-1 in ameliorating UC symptoms.

Main Methods:

• Ulcerative colitis was induced in CT-1 knockout and wild-type mice using dextran sulphate sodium (DSS).
• Exogenous CT-1 or vehicle was administered to colitic mice, and disease activity, inflammatory markers, colon damage, apoptosis, and bacterial translocation were assessed.

Main Results:

• CT-1 knockout mice exhibited exacerbated colon damage and disease severity compared to wild-type mice.
• Exogenous CT-1 treatment significantly reduced colon damage, disease activity index, and key inflammatory markers (TNF-α, INFγ, IL-17, iNOS).
• CT-1 treatment also decreased apoptosis, enhanced NFκB and STAT3 activation, and prevented bacterial translocation.

Conclusions:

• Endogenous CT-1 plays a crucial role in the colon's defense and repair mechanisms against ulcerative lesions.
• Exogenous CT-1 demonstrates significant therapeutic potential for ulcerative colitis by exerting anti-inflammatory and anti-apoptotic effects.